350
Participants
Start Date
May 9, 2022
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
MOB015B
Applied topically for 48 weeks
Vehicle (Placebo Comparator)
Applied topically for 48 weeks
Weill Cornell Medicine Dermatology, New York
Forest Hills Dermatology Group, Kew Gardens
Skin Search of Rochester, Rochester
UPMC Department of Dermatology, Pittsburgh
Martin Foot and Ankle, York
Virginia Clinical Research, Inc., Norfolk
UNC Dermatology and Skin Cancer Center, Chapel Hill
Coastal Carolina Research Center, North Charleston
Driven Research LLC, Coral Gables
Doctors Research Institute Corporation, South Miami
Olympian Clinical Research, Clearwater
University of Alabama Hospital, Birmingham
Tennessee Clinical Research Center, Nashville
Haber Dermatology, Inc., Beachwood
The South Bend Clinic, LLC, South Bend
Michigan Center for Skin Care Research, Clinton Township
David Fivenson, MD, Dermatology, PLLC, Ann Arbor
Associated Skin Care Specs, New Brighton
Podiatry 1st, O'Fallon
Skin Specialists, PC, Omaha
DelRicht Research - Baton Rouge, Baton Rouge
IMA Clinical Research, Monroe
Houston Center for Clinical Research, Sugar Land
Progressive Clinical Research, PA, San Antonio
Futuro Clinical Trials LLC, McAllen
DermResearch, Inc., Austin
Colorado Medical Research Center, Denver
Dermatology Research Associates, Los Angeles
California Dermatology & Clinical Research Institute, Encinitas
Center for Clinical Research, San Francisco
Center for Dermatology Clinical Research,Inc, Fremont
Oregon Dermatology and Research Center, Portland
Hassman Research Institute, Berlin
Mediprobe Research, London
Toronto Research Centre, Toronto
Lead Sponsor
Moberg Pharma AB
INDUSTRY